18 June 2013
Keywords: ligand, targretin, new, data, expected, pharmaceuticals, says
Article | 29 March 2000
Ligand Pharmaceuticals says that it expects to reveal data from pivotaltrials of Targretin (bexarotene) capsules from patients with moderate-to-severe plaque ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.